Treatment of refractory testis cancer: Salvage or savage chemotherapy?

This publication has 30 references indexed in Scilit:

• Dose intensity and outcome with combination chemotherapy for germ cell carcinoma
  European Journal of Cancer and Clinical Oncology, 1989
• Chemotherapy for Poor Risk Germ Cell Tumours An Independent Evaluation of the POM B/ACE Regime
  British Journal of Urology, 1988
• Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the Urothelium
  New England Journal of Medicine, 1988
• Chemotherapy with maximally tolerable doses of VP 16-213 and cyclophosphamide followed by autologous bone marrow transplantation for the treatment of relapsed or refractory germ cell tumors
  European Journal of Cancer and Clinical Oncology, 1988
• Prognostic factors in metastatic testicular cancer
  International Journal of Andrology, 1987
• Multivariate analysis of prognostic variables in patients with disseminated non‐seminomatous testicular cancer: results from an EORTC multi‐institutional phase III study
  International Journal of Andrology, 1987
• Efficacy of ifosfamide in refractory malignant diseases and uroprotection by mesna: results of a clinical phase II-study with 151 patients
  Cancer Treatment Reviews, 1983
• Surgery in patients with advanced germ cell malignancy following a clinical partial response to chemotherapy
  Journal of Surgical Oncology, 1983
• Etoposide and etoposide-ifosfamide therapy for refractory testicular tumors
  Cancer Treatment Reviews, 1982
• Non‐seminoma Germ Cell Tumours (Malignant Teratoma) of the Testis Results of Treatment and an Analysis of Prognostc Factors*
  British Journal of Urology, 1981